59
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Interleukin-32: a cytokine and inducer of TNFalpha.

      1 , , , ,
      Immunity
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We describe the gene structure, regulation, signal transduction. and functions of a cytokine, interleukin (IL)-32. An IL-18 unresponsive cell was converted to a responsive cell by transfection of the IL-18 receptor beta chain, and IL-18-induced microarray revealed high expression of a cytokine-like gene. Although IL-32 does not share sequence homology with known cytokine families, IL-32 induces various cytokines, human TNFalpha, and IL-8 in THP-1 monocytic cells as well as mouse TNFalpha and MIP-2 in Raw macrophage cells. IL-32 activates typical cytokine signal pathways of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activated protein kinase. IL-32 mRNA is highly expressed in immune tissue rather than other tissues. Human IL-32 exists as four splice variants, and IL-32 from other species were found as expressed sequence tag clones in the databank. Induced in human peripheral lymphocyte cells after mitogen stimulation, in human epithelial cells by IFNgamma, and in NK cells after exposure to the combination of IL-12 plus IL-18, IL-32 may play a role in inflammatory/autoimmune diseases.

          Related collections

          Author and article information

          Journal
          Immunity
          Immunity
          Elsevier BV
          1074-7613
          1074-7613
          Jan 2005
          : 22
          : 1
          Affiliations
          [1 ] Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. soohyun.kim@uchsc.edu
          Article
          S1074-7613(04)00380-2
          10.1016/j.immuni.2004.12.003
          15664165
          eef8bbe0-c09c-4ef2-af8a-c60e0b073dfd
          History

          Comments

          Comment on this article